A biobank is a type of biorepository which stores the biological samples, usual humans for use in future research. These biobanks play a vital role in drug discovery and disease research. Biobanks Market is accounted for USD XX billion in 2017 and expected to grow at a CAGR of X% to reach USD XX billion by 2024.
Biobanks Market Share:
Biobanks market is segmented by product, samples, application, and geography. On basics of applications, the largest share is in North America especially the US for the betterment of the medical facilities and growing number of biotechnology and pharmaceutical services.
Biobanks Market Size:
Raising blood-related diseases, increase in research on the cell, gene and drugs have driven the marketplace for biobanks in North America, followed by Europe. In the forecast period, Asia-Pacific is going to have the highest growth rate in the market.
Biobanks Market Growth:
The market for biobanks is driven
Biobanks Market Industrial Analysis:
Biobank Market is segmented on the basis of product, sample, applications, and geography. In this classification, the growth of the market is driven by application segment classified into Drug Discovery and research field. In the forecast period, Asia-Pacific is expected to grow at a quick pace.
Biobanks Market Outlook:
Biobanks are primarily used to reduce the side effects of drugs and in personal medication, for instance, in research and drug development further increased the demand for biobanks across various verticals and its predominant in North America especially the US.
Biobanks Market Trends:
Thermo Fisher Scientific Inc., acquired Patheon, a Contract Development, and Manufacturing Company in May 2017.
Brooks Automation, Inc. has acquired Cool Labs a subsidiary of BioCision, LLC., on November 2017.
Biobanks Market Research Reports:
Starting from $2700
Starting from $2700
Starting from $2700
Keep up-to-date with our weekly newsletter, Media Pulse.